IRD vs WELL · rev $11.0M vs P/E 100, rev $10.84B
Opus Genetics, Inc. (IRD) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
IRD currently screens at market cap $35.7M. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the IRD and WELL stock pages for the full models.
Not investment advice.